Pazonat 400mg Tablet is a protein kinase inhibitor used in the treatment of kidney cancer and soft tissue sarcoma.

Pazonat 400mg Tablet is used to treat different types of cancer

Uses of Pazonat Tablet

Benefits of Pazonat Tablet

In Kidney cancer

Pazonat 400mg Tablet is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor’s instructions very carefully to recover.

In Soft tissue sarcoma

Soft tissue sarcoma is a type of sarcoma that develops in tissues such as bone and muscles. Pazonat 400mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully and let your doctor know if any of the side effects bother you.

show less

Side effects of Pazonat Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Pazonat

Headache
Nausea
Vomiting
Musculoskeletal (bone, muscle or joint) pain
Fatigue
Change in color of hair
Diarrhea
High blood pressure
Decreased appetite
Weight loss
Taste change
Abnormal skin pigmentation
Hair discoloration
Tumor pain
Breathlessness

How to use Pazonat Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Pazonat 400mg Tablet is to be taken empty stomach.

How Pazonat Tablet works

Pazonat 400mg Tablet is an anti-cancer medication. It works by binding and inhibiting the enzyme receptors (tyrosine kinase) that are responsible for the proliferation of the cancerous cells. It also restricts the growth of new blood vessels within the tumor. This is how it works against cancer.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Pazonat 400mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Pazonat 400mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding

UNSAFE

Pazonat 400mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

UNSAFE

Pazonat 400mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

SAFE IF PRESCRIBED

Pazonat 400mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Pazonat 400mg Tablet is recommended.

Liver

CAUTION

Pazonat 400mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Pazonat 400mg Tablet may be needed. Please consult your doctor.
Use of Pazonat 400mg Tablet is not advised in patients with moderate to severe liver disease.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Pazonat 400mg Tablet

₹300.0/Tablet

Votrient 400mg Tablet

Glaxo SmithKline Pharmaceuticals Ltd

₹579/tablet

93% costlier

Pazoci 400 Tablet

Cipla Ltd

₹266.53/tablet

11% cheaper

Pazolee 400mg Tablet

Admac Pharma Ltd

₹530/tablet

77% costlier

Pazolit 400mg Tablet

Sun Pharmaceutical Industries Ltd

₹183.33/tablet

39% cheaper

Pazroto 400mg Tablet

Abbott

₹350/tablet

17% costlier

View all substitutes

Fact Box

Chemical Class

Alkyldiarylamines Derivative

Habit Forming

Therapeutic Class

abcde

Action Class

Tyrosine kinase inhibitors

Patient concerns

i'm patient of Ewing sarcoma bone cancer

Dr. Vijay Sharnangat

Medical Oncology and Hematology

How can I help you.

Fracture in right leg claw &ligament soft tissue fracture

Dr. Akshat Goel

Orthopaedics

Share recent X-rays and MRI reports

Related lab tests

Complete Blood Count

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1072-73.
Pazopanib. Research Triangle Park, North Carolina: GlaxoSmithKline; 2009 [revised Apr. 2012]. [Accessed 24 Jan. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:

Marketer details

Name: Natco Pharma Ltd

Address: Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Country of origin: India
Expires on or after: February, 2025

A licensed vendor partner from your nearest location will deliver Pazonat 400mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

MRP

₹9000

Inclusive of all taxes

30.0 tablets in 1 bottle

Add to cart

Online payment only

We provide you with authentic, trustworthy and relevant information

Have issue with the content?